136 related articles for article (PubMed ID: 29689270)
1. Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.
Panella M; Mosca N; Di Palo A; Potenza N; Russo A
Biochem Biophys Res Commun; 2018 Jun; 500(3):824-827. PubMed ID: 29689270
[TBL] [Abstract][Full Text] [Related]
2. Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
Coppola N; de Stefano G; Panella M; Onorato L; Iodice V; Minichini C; Mosca N; Desiato L; Farella N; Starace M; Liorre G; Potenza N; Sagnelli E; Russo A
Oncotarget; 2017 Apr; 8(15):25289-25299. PubMed ID: 28445974
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells.
Potenza N; Mosca N; Zappavigna S; Castiello F; Panella M; Ferri C; Vanacore D; Giordano A; Stiuso P; Caraglia M; Russo A
J Cell Physiol; 2017 Jul; 232(7):1907-1913. PubMed ID: 27982429
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells.
Potenza N; Panella M; Castiello F; Mosca N; Amendola E; Russo A
Sci Rep; 2017 Sep; 7(1):10712. PubMed ID: 28878257
[TBL] [Abstract][Full Text] [Related]
5. A Novel ceRNA Regulatory Network Involving the Long Non-Coding Antisense RNA SPACA6P-AS, miR-125a and its mRNA Targets in Hepatocarcinoma Cells.
Di Palo A; Siniscalchi C; Mosca N; Russo A; Potenza N
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709089
[TBL] [Abstract][Full Text] [Related]
6. ZEB1 causes the production of hsa-microRNA-99b/let-7e/microRNA-125a cluster and promotes invasion of liver cancer cells.
Wang XF; Liu JY; Li JL; Wang FZ; Sun BL
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1468-1475. PubMed ID: 30840268
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.
Bi Q; Tang S; Xia L; Du R; Fan R; Gao L; Jin J; Liang S; Chen Z; Xu G; Nie Y; Wu K; Liu J; Shi Y; Ding J; Fan D
PLoS One; 2012; 7(6):e40169. PubMed ID: 22768249
[TBL] [Abstract][Full Text] [Related]
8. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
[TBL] [Abstract][Full Text] [Related]
9. Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.
Wang YC; Chen YL; Yuan RH; Pan HW; Yang WC; Hsu HC; Jeng YM
Carcinogenesis; 2010 Sep; 31(9):1516-22. PubMed ID: 20525879
[TBL] [Abstract][Full Text] [Related]
10. Proto-oncogene Zbtb7a represses miR-125a-5p transcription in hepatocellular carcinoma cells.
Di Palo A; Siniscalchi C; Mosca N; Russo A; Potenza N
Mol Biol Rep; 2020 Jun; 47(6):4875-4878. PubMed ID: 32410140
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
[TBL] [Abstract][Full Text] [Related]
13. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6.
Zhu H; Wang G; Zhou X; Song X; Gao H; Ma C; Chang H; Li H; Liu FF; Lu J; Ma J
Biomed Pharmacother; 2016 Oct; 83():792-797. PubMed ID: 27490780
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative Activity of microRNA-125a and its Molecular Targets.
Russo A; Potenza N
Microrna; 2019; 8(3):173-179. PubMed ID: 30394225
[TBL] [Abstract][Full Text] [Related]
15. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
Zhao J; Xu T; Wang F; Cai W; Chen L
Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
[TBL] [Abstract][Full Text] [Related]
16. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
Qin X; Wan Y; Wang S; Xue M
Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
19. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
Zhang Y; Zheng D; Xiong Y; Xue C; Chen G; Yan B; Ye Q
FEBS Lett; 2014 May; 588(10):1913-20. PubMed ID: 24704686
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.
Zou CD; Zhao WM; Wang XN; Li Q; Huang H; Cheng WP; Jin JF; Zhang H; Wu MJ; Tai S; Zou CX; Gao X
Oncotarget; 2016 Jan; 7(1):266-78. PubMed ID: 26497556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
